Technical Analysis for GKOS - Glaukos Corporation

Grade Last Price % Change Price Change
D 48.65 0.76% 0.37
GKOS closed up 0.5 percent on Monday, January 30, 2023, on 1.19 times normal volume.
Earnings due: Feb 20
*** please verify all earnings dates ***

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Up Flat

Date Alert Name Type % Chg
Gapped Down Weakness 0.76%
NR7 Range Contraction 1.26%
Inside Day Range Contraction 1.26%
Gapped Up Strength 0.97%
Gapped Down Weakness 1.45%
Fell Below 200 DMA Bearish 0.99%
Overbought Stochastic Strength 0.99%
Gapped Down Weakness 0.99%
Crossed Above 200 DMA Bullish -1.01%
Overbought Stochastic Strength -1.01%

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
60 Minute Opening Range Breakout 27 minutes ago
Up 2% 27 minutes ago
Rose Above 200 DMA about 1 hour ago
Rose Above Previous Day's High about 2 hours ago
200 DMA Resistance about 2 hours ago

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Glaukos Corporation Description

Glaukos Corporation (Glaukos) is an ophthalmic medical technology company. The Company is engaged in the development and commercialization of products and procedures for the treatment of glaucoma. Glaukos has developed the micro-invasive glaucoma surgery (MIGS) for glaucoma treatment. It offers iStent, an MIGS device measuring one millimeter long and 0.33 millimeter wide. MIGS procedures involve the insertion of a micro-scale device from within the eye's anterior chamber through a small corneal incision. Glaukos is also engaged in developing a portfolio of micro-scale injectable therapies, including three pipeline products, namely, the iStent Inject, the iStent Supra and iDose. The iStent Inject includes two stents pre-loaded in an auto-injection inserter. The iStent Supra is designed to access an alternative drainage space within the eye. iDose is an implant that is designed to provide a sustained release of a prostaglandin drug to lower intraocular pressure in glaucoma patients.


Classification

Sector: Healthcare
Industry: Medical Instruments & Supplies
Keywords: Medicine Eye Surgery Medical Technology Ophthalmology Ophthalmic Drainage Glaucoma Vision Implant Blindness Incision Eye Surgery Treatment Of Glaucoma Cornea Intraocular Pressure

Is GKOS a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 64.49
52 Week Low 33.33
Average Volume 337,054
200-Day Moving Average 48.78
50-Day Moving Average 45.94
20-Day Moving Average 47.00
10-Day Moving Average 48.44
Average True Range 1.52
RSI 58.68
ADX 19.8
+DI 25.72
-DI 17.81
Chandelier Exit (Long, 3 ATRs) 45.67
Chandelier Exit (Short, 3 ATRs) 45.01
Upper Bollinger Bands 50.87
Lower Bollinger Band 43.13
Percent B (%b) 0.67
BandWidth 16.47
MACD Line 0.85
MACD Signal Line 0.74
MACD Histogram 0.1139
Fundamentals Value
Market Cap 2.17 Billion
Num Shares 45 Million
EPS 0.37
Price-to-Earnings (P/E) Ratio 130.49
Price-to-Sales 15.31
Price-to-Book 4.82
PEG Ratio 1.64
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 50.38
Resistance 3 (R3) 50.31 49.54 50.03
Resistance 2 (R2) 49.54 49.00 49.57 49.91
Resistance 1 (R1) 48.91 48.67 49.22 48.98 49.79
Pivot Point 48.14 48.14 48.30 48.17 48.14
Support 1 (S1) 47.51 47.61 47.83 47.58 46.77
Support 2 (S2) 46.74 47.28 46.78 46.65
Support 3 (S3) 46.11 46.74 46.53
Support 4 (S4) 46.18